21st Century Cures to host roundtable

The House Energy and Commerce Committee's 21st Century Cures initiative will host a roundtable June 24 to discuss how technology can accelerate discovery, development and delivery of new cures and treatments. Participants include Jeffrey Shuren, director of FDA's Center for Devices and Radiological Health (CDRH); Anne Wojcicki, CEO and co-founder of 23andMe Inc. (Mountain View, Calif.) and Brian Druker, director of the Knight Cancer Center at the Oregon Health and Science University who worked on the development of CML drug Gleevec imatinib. ...